Increasing Prevalence of Diabetic Population, and Increasing Obesity rates to Drive the Insulin Pump Demand Globally: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Insulin pump is a small medical or computerized device that delivers insulin for the cure of diabetes, also called continuous subcutaneous insulin therapy. It has a reservoir, control module, an infusion set that contains a cannula &tubing system. It is integrated with the transmitter, receiver, and a sensor. It is programmed to release insulin in incessant small basal dose and a bolus dose. It delivers & regulates blood sugar level in body. It is classified into many types such as tethered pumps, untethered pumps and implantable pumps. According to study, “Worldwide Insulin Pump Market – Drivers, Opportunities, Trends, and Forecasts: 2017-2023” some of the major companies that are currently working in the worldwide insulin pump market are Animus Corp,B. Braun Melsungen AG, Abbott Laboratories, Medtronics Inc, Roche Diagnostics, NovoNordisk, Carestream Health Inc., Debiotech S.A, Becton Dickinson and Company, Insulet Corp, Apex Medical, MicroPortScientific Corp, Eli Lilly and Company, New Genix, Cellnovo Ltd., Nipro Diagnostic Inc., Jiangsu Delfu Co. Ltd., Sanofi, Asante Solutions, Insujet, Phray, Valeritas, Inc., Twobiens, Scientific Corporation, Shinmyung Mediyes, Fornia, F. Hoffmann-La Roche Ltd., Top Corporation, MedNovo, Ypsomed HoldingAG, Tandem Diabetes Care Inc., GlySens ICGM, Carestream Health Inc., Sooil Development Co. Based on the product, the insulin pump market is segmented into smart pump, disposable insulin pump and traditional insulin pump. Traditional pumps include tubing, straight sets, infusion set, angled sets and tubing etc. Based on accessories, the market is segmented into insulin reservoirs or cartridges, infusion sets and infusion set insertion devices. Based on distribution channel, the market is segmented into retail pharmacy, hospital pharmacy, diabetes clinics or centers and online sales. The key benefits include precise insulin delivery, increased flexibility in lifestyle, reducing wide fluctuations in blood glucose, discrete blousing, easier control of hormonal spikes, help with the dawn phenomenon, exercise with confidence, fewer injections, predictable insulin delivery and reducing episodes of severe hypoglycemia. Some of the major drawbacks are risk of diabetic ketoacidosis (DKA), being attached 24/7, technical difficulties, risk of skin infections at catheter site and high cost of pumps etc. The insulin pump market is primarily driven by increasing prevalence of diabetic population, re-sales of insulin pumps, increasing obesity rates, increased adoption of advanced technology products, increasing disposable income, growing awareness of insulin pumps in the emerging markets, longer life expectancy at birth, potential increase in the number of aged population, rising healthcare expenditure, rising incidences of government initiatives and significant focus on diabetes management. Apart from the key advantages some of the major limitations of the market include unfavorable reimbursement plans, issues related to product pricing, threat of technological substitutes and acute competition in the market. Additionally, some of the key opportunities creating the use of insulin pumps are technological advancements, rising medical tourism in developing countries, latest product launches, substitute for conventional diabetes treatments and significant increase in the number of mergers & acquisitions. During the 2017-2023 forecast periods, the insulin pumps market is anticipated to witness a CAGR of 8.3%. It is expected that the market to reach US $8520.9 million, by 2023. It is estimated that the market will be growing rapidly as a result of a huge pool of undiagnosed diabetic patients & emergent demand for ambulatory infusion systems. For more information, click on the link below: https://www.kenresearch.com/healthcare/medical-devices/worldwide-insulin-pump/173118-91.html Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications sales@kenresearch.com +91 9015378249 Tags: Animus Corp Worldwide Insulin Pump, AsanteAsante Worldwide Insulin Pump, Cellnovo LtdCellnovo Ltd Worldwide Insulin Pump, Diabetes Drugs Market, Diabetes Management Market, Global Insulin Pump Market Analysis, Global Insulin Pumps Industry Growth, Infusion Pumps Market, Insulet Corp Insulet Corp Worldwide Insulin Pump, Insulin Pump Market Competitive Strategies, Medtronics IncMedtronics Inc Worldwide Insulin Pump, Nipro Diagnostic IncNipro Diagnostic Inc, Roche Diagnostics Roche Diagnostics Worldwide Insulin Pump, Worldwide Insulin Pump Industry Overview, Worldwide Insulin Pump Industry Research Report, Worldwide Insulin Pump Market, Worldwide Insulin Pump Market Application, Worldwide Insulin Pump Market Attractiveness, Worldwide Insulin Pump Market Business Strategy, Worldwide Insulin Pump Market Competitive Landscape, Worldwide Insulin Pump Market Demand Worldwide Insulin Pump Industry Outlook, Worldwide Insulin Pump Market Drivers, Worldwide Insulin Pump Market Dynamics, Worldwide Insulin Pump Market Forecast, Worldwide Insulin Pump Market Opportunities, Worldwide Insulin Pump Market Research Report, Worldwide Insulin Pump Market Restraints, Worldwide Insulin Pump Market Segmentation, Worldwide Insulin Pump Market Share, Worldwide Insulin Pump Market SWOT Analysis, Worldwide Insulin Pump Market Trends